These organizations will be the first to participate in Orphan ClinDevNet, a connected ecosystem of partners OTXL will rely on for clinical- and commercial-stage services. The Orphan Therapeutics ...

Incyte Corporation INCY is expected to beat estimates when it reports first-quarter 2025 earnings results on April 29, before ...

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 10.12%, which has investors questioning if this is right time to sell.

As previously reported, BofA analyst Jason Gerberry upgraded United Therapeutics (UTHR) to Neutral from Underperform with an unchanged price ...

This put -% of the company's publicly available shares short. Short interest in TransCode Therapeutics Corp (XNAS:RNAZ) decreased during the last reporting period, falling from 280.30M to 275.20M.

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

PTC Therapeutics, Inc.’s PTCT share price has surged by 6.72%, which has investors questioning if this is right time to sell.

The 340B program requires drugmakers who want to participate in Medicaid and Medicare to discount their prices for hospitals, ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...